These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19591602)

  • 1. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver.
    Deering KN; Shannon K; Sinclair H; Parsad D; Gilbert E; Tyndall MW
    AIDS Patient Care STDS; 2009 Aug; 23(8):603-9. PubMed ID: 19591602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women.
    Simoni JM; Pantalone DW; Plummer MD; Huang B
    Health Psychol; 2007 Jul; 26(4):488-95. PubMed ID: 17605569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study.
    Broadhead RS; Heckathorn DD; Altice FL; van Hulst Y; Carbone M; Friedland GH; O'Connor PG; Selwyn PA
    Soc Sci Med; 2002 Jul; 55(2):235-46. PubMed ID: 12144138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention.
    Broadhead RS; Heckathorn DD; Weakliem DL; Anthony DL; Madray H; Mills RJ; Hughes J
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):42-57. PubMed ID: 9722809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project.
    Parsons JT; Rosof E; Punzalan JC; Di Maria L
    AIDS Patient Care STDS; 2005 Jan; 19(1):31-9. PubMed ID: 15665633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside.
    Shannon K; Bright V; Duddy J; Tyndall MW
    J Urban Health; 2005 Sep; 82(3):488-97. PubMed ID: 15944404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.
    Cohn SE; Umbleja T; Mrus J; Bardeguez AD; Andersen JW; Chesney MA
    AIDS Patient Care STDS; 2008 Jan; 22(1):29-40. PubMed ID: 18442305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.
    Martin M; Del Cacho E; Codina C; Tuset M; De Lazzari E; Mallolas J; Miró JM; Gatell JM; Ribas J
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1263-8. PubMed ID: 18834323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
    Fairley CK; Permana A; Read TR
    HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: access, adherence and outcomes.
    Tyndall MW; McNally M; Lai C; Zhang R; Wood E; Kerr T; Montaner JG
    Int J Drug Policy; 2007 Aug; 18(4):281-7. PubMed ID: 17689376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
    Zorrilla CD; Santiago LE; Knubson D; Liberatore K; Estronza G; Colón O; Acevedo M
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
    Silveira MP; Maurer P; Guttier MC; Moreira LB
    J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting.
    Milloy MJ; King A; Kerr T; Adams E; Samji H; Guillemi S; Wood E; Montaner J
    J Int AIDS Soc; 2016; 19(1):20617. PubMed ID: 27094914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study.
    Macalino GE; Mitty JA; Bazerman LB; Singh K; McKenzie M; Flanigan T
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S393-7. PubMed ID: 15156428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adapting an adherence support workers intervention: engaging traditional healers as adherence partners for persons enrolled in HIV care and treatment in rural Mozambique.
    Audet CM; Salato J; Vermund SH; Amico KR
    Implement Sci; 2017 Apr; 12(1):50. PubMed ID: 28407813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.